🇺🇸 FDA
Patent

US 9820964

Ultrapure tetrahydrocannabinol-11-oic acids

granted A61KA61K31/352A61K9/0014

Quick answer

US patent 9820964 (Ultrapure tetrahydrocannabinol-11-oic acids) held by Corbus Pharmaceuticals, Inc. expires Mon Nov 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Corbus Pharmaceuticals, Inc.
Grant date
Tue Nov 21 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61K, A61K31/352, A61K9/0014, A61K9/0019, A61K9/0048